Literature DB >> 16611872

Bosentan may induce arthritis flare in patients with scleroderma concomitantly treated with methotrexate.

F Cozzi, P A Ostuni, H Marotta, P Sfriso, M Favaro, S Todesco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16611872      PMCID： PMC1798114          DOI： 10.1136/ard.2005.044388

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Bosentan therapy for pulmonary arterial hypertension.

Authors:  Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael Landzberg; Gerald Simonneau
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

2.  Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients.

Authors:  R A Herman; P Veng-Pedersen; J Hoffman; R Koehnke; D E Furst
Journal:  J Pharm Sci       Date:  1989-02       Impact factor: 3.534

3.  Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression.

Authors:  G S Alarcón; R E Schrohenloher; A A Bartolucci; J R Ward; H J Williams; W J Koopman
Journal:  Arthritis Rheum       Date:  1990-08

4.  Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Authors:  R N Channick; G Simonneau; O Sitbon; I M Robbins; A Frost; V F Tapson; D B Badesch; S Roux; M Rainisio; F Bodin; L J Rubin
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

5.  The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells.

Authors:  J P Hinson; G P Vinson; S Kapas; R Teja
Journal:  J Endocrinol       Date:  1991-02       Impact factor: 4.286

6.  Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study.

Authors:  Olivier Sitbon; David B Badesch; Richard N Channick; Adaani Frost; Ivan M Robbins; Gérald Simonneau; Victor F Tapson; Lewis J Rubin
Journal:  Chest       Date:  2003-07       Impact factor: 9.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.